NCT00819312View on ClinicalTrials.gov

YAZ, Oral Contraceptive Registration in China

PHASE3CompletedINTERVENTIONAL
Enrollment

675

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Contraception
Interventions
DRUG

YAZ (SH T00186, BAY86-5300)

20ug ethinylestradiol, 3mg drospirenone, tablet, orally, opd

Trial Locations (17)

100034

Beijing

100044

Beijing

110004

Shenyang

200011

Shanghai

200127

Shanghai

210006

Nanjing

210009

Nanjing

225001

Yangzhou

400010

Chongqing

430022

Wuhan

510120

Guangzhou

710032

Xi’an

Unknown

Guangzhou

Jinan

Chengdu

Chongqing

Hong Kong

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY